NASDAQ
Alseres Pharmaceuticals, Inc. (ALSE) has a price/fcf ratio of -0.43x as of Tuesday, May 26, 2026. This represents a 37.95% increase compared to its 12-month average of -0.69x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.